Sudarshan Pharma Industries Share Price

Small Cap | Pharmaceuticals and health care | BSE: 543828

₹29.00 image-0.51 (-1.73 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 29.51

High (₹) 29.75

Low (₹) 29.00

Prev. Close (₹) 29.51

Volume 24,000

VWAP (₹) 29.35

ROCE (%) 19.76

Industry P/E 43.95

TTM P/E 55.77

P/B Ratio 0.62

Market Cap (₹) Cr.697.91

Dividend Yield (%)--

EPS (₹) 4.76

ROE10.25%

Sales Growth (%) 0.48

Profit Growth (%)62.79

Day Range

29.7529.75

L
H

52 Week Range

5.8253.50

L
H

Historical Returns

Returns (6M)

-4.16 %

Returns (1Y)

268.96 %

Returns (3Y)

317.87 %

Returns (5Y)

317.87 %

Returns (6M)

-4.16 %

Returns (1Y)

268.96 %

Returns (3Y)

317.87 %

Returns (5Y)

317.87 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Increasing Annual Revenue for Past 2 Years
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 46.74

MFI 12.19

ATR 1.69

Commodity Channel Index -156.33

ROC125 71.35

ROC21 -32.08

Williams %R -100.00

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current29.3629.4329.4629.3329.2629.2329.16
Week Ago34.2335.5436.3533.4232.1131.3029.99
Month Ago42.3042.3042.3042.3042.3042.3042.30

EMA & SMA
info_icon

29.00

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 32.09


9 Day 32.91


10 Day 33.17


12 Day 33.97


14 Day 34.27

20 Day 36.25


26 Day 37.80


50 Day 40.86


100 Day 40.60


200 Day 27.92

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
NORTH STAR OPPORTUNITIES FUND VCC-BULL VALUE INCORPORATED VCC SUB-FUNDbulkBuy11 Feb, 2025₹35.7315,00,000BSE
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkSell01 Jan, 2025₹44.3512,48,000BSE
SETU SECURITIES PVT LTDbulkBuy01 Jan, 2025₹44.3512,48,000BSE
CENTURY INDIA OPPORTUNITY FUND PCbulkBuy28 Nov, 2024₹41.9716,00,000BSE
SAROJ GUPTAbulkSell25 Sept, 2024₹424.3575,200BSE
EPITOME TRADING AND INVESTMENTSbulkSell25 Sept, 2024₹421.921,53,600BSE
SAROJ GUPTAbulkBuy25 Sept, 2024₹411.001,50,400BSE
EPITOME TRADING AND INVESTMENTSbulkBuy25 Sept, 2024₹424.331,34,400BSE
BISHWANATH PRASAD AGRAWALbulkBuy25 Sept, 2024₹412.411,39,200BSE
SHYAMSAKHA BROKING SERVICES PRIVATE LIMITEDbulkSell23 Sept, 2024₹385.851,31,200BSE

Insider Trading

No insider trading details available.

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
30 Sept, 2024Stock split from Rs. 10/- to Re. 1/-.22 Nov, 202423 Nov, 2024
26 May, 2023Rs.0.3000 per share(3%)Final Dividend25 Aug, 202301 Jan, 1970

Announcements

DateSourceDetail
06 Mar, 2025BSE IndiaWe inform you that at the meeting of Board of Directors of the Company on 6th March, 2025 the Board has, on the recommendation of the Nomination and Remuneration Committee, with Consent of Mr. Manoj Lodha, appointed Mr. Manoj Lodha as an Executive Director and Chief Financial Officer of the Company w.e.f. 1st April, 2025.
06 Mar, 2025BSE IndiaWe inform you that the Board of Director have accepted the resignation of Mr. Sachin Mehta as Chief Financial Officer of the Company w.e.f. 1st April, 2025, However Mr. Sachin Mehta shall continue as the Joint Managing Director of the Company.
04 Mar, 2025BSE IndiaPursuant to Regulation 30(6) of SEBI Listing Regulations, this is to inform you that the Company will be meeting Investors / Analysts on 07-March-2025. \r\n\r\nKindly take the same on record.
26 Feb, 2025BSE IndiaIn continuation of the Company''s disclosure dated 29-Nov-2024, this is to inform you that the Company has acquired 10,000 ordinary shares of Sudarshan Pharma Industries Private Limited, Singapore (Unique Entity Number 202327475M). \r\n\r\nConsequent to the aforesaid acquisition, Sudarshan Pharma Industries Private Limited has become a wholly-owned subsidiary of the Company.
19 Feb, 2025BSE IndiaThis is to inform you that the Board of Directors of the Company have approved to incorporate a limited liability company in Poland as a wholly-owned subsidiary. Details required vide SEBI circular dated 13-July-2023 are given in the annexure.
05 Feb, 2025BSE IndiaPursuant to Regulation 44(3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 5th February 2025 through video conferencing / other audio-visual means.
05 Feb, 2025BSE IndiaPursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio-visual means.
04 Feb, 2025BSE IndiaWe inform you that an Extraordinary General Meeting of the Company was held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio visual means. Pursuant to Regulation 30 and part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a summary of the proceedings of Extraordinary General Meeting.
31 Jan, 2025BSE IndiaCorrigendum to Notice of Extra-Ordinary General Meeting dated 10-Jan-2025 about certain alterations / modifications / additions made in the Resolution and Explanatory Statement pertaining to item no. 1 of EGM Notice dated 10-Jan-2025.
31 Jan, 2025BSE IndiaIn continuation of the outcome of Board Meeting held on 10-Jan-2025, Fund Raising Committee of the Board at its meeting held on 30-Jan-2025 approved, inter alia, revision in list of allottees and change in Notice of EGM and issue of Corrigendum to the Notice of Extraordinary General Meeting scheduled on Tuesday, 04-Feb-2025.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
To consider issue of Warrants--06 Jan, 202510 Jan, 2025
Half Yearly Results--28 Oct, 202431 Oct, 2024
Stock Split--25 Sept, 202430 Sept, 2024
OthersInter alia, (1) To consider proposal for raising of funds by way of issue of one or more of instruments comprising of equity shares, convertible securities of any other description or warrants etc.17 Jul, 202404 Jul, 2024
Audited Results--22 May, 202427 May, 2024
OthersInter alia, to consider : 1. To give authority to appoint consultants and/or representatives. 2. To avail the credit facility.23 Mar, 202428 Mar, 2024
Half Yearly Results & ESOP--06 Nov, 202310 Nov, 2023
OthersInter alia, to consider : To give approval for incorporating a subsidiary company in the name and style of "LIFESCIENCES CHEMICAL PRIVATE LIMITED", in the state of Gujarat.17 Aug, 202318 Aug, 2023
Others--28 Jul, 202302 Aug, 2023
Final Dividend & ESOP--18 Jul, 202321 Jul, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Mar, 2024Sept, 2023

About Sudarshan Pharma Industries

Sudarshan Pharma Industries is a Public Limited Listed company incorporated on 23/07/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U51496MH2008PLC184997 and registration number is 184997. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 465.56 Cr. and Equity Capital is Rs. 24.07 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

2008

Managing Director

Mr. Hemal V Mehta

NSE Symbol

--

Sudarshan Pharma Industries Management

NameDesignation
Mr. Hemal V MehtaChairman & Managing Director
Mr. Sachin V MehtaJoint Managing Director
Mrs. Jaya Ankur SinghaniaIndependent Director
Dr. Umesh LuthraIndependent Director
Dr. Anil GhogareIndependent Director
Mr. Rushabh PatilIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Sudarshan Pharma Industries

What is the share price of Sudarshan Pharma Industries?

The share price of Sudarshan Pharma Industries on 13 Mar, 2025 is ₹ 29.00.

What is 52W high and 52W low share price of Sudarshan Pharma Industries?

The highest and lowest 52W share prices of Sudarshan Pharma Industries are ₹ 53.500 and ₹ 5.820

What is the market cap of Sudarshan Pharma Industries?

The market capitalization of Sudarshan Pharma Industries as of 13 Mar, 2025 is ₹ 697.91 Crores

What is the P/E ratio of Sudarshan Pharma Industries?

The current P/E ratio of Sudarshan Pharma Industries as of 13 Mar, 2025 is 43.95

What is the PB ratio of Sudarshan Pharma Industries?

The PB ratio of Sudarshan Pharma Industries as of 13 Mar, 2025 is 0.62

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited